Our Chairman and CEO John F. Crowley has co-authored an article for @STATNews: “Beating COVID-19 Will Change How New Therapies are Developed”, exploring how the pandemic will potentially transform the future of drug development. https://t.co/giLJrx2Rla
— Amicus Therapeutics (@amicusrx1) May 27, 2020
America’s biopharmaceutical industry has lost the trust of many of our patients. We’re committed to reversing this trend by pledging a new Commitment to Patients and the Public: https://t.co/PSg4lK6T2B
— Amicus Therapeutics (@amicusrx1) January 30, 2020
The #European Biotech Social Pact is a collective step to expand medical innovation in Europe. Our Chairman & CEO John F. Crowley co-authored this pact that strengthens the biotechnology industry’s commitment to putting patients first. Read more here: https://t.co/2LKUetIXk2
— Amicus Therapeutics (@amicusrx1) October 1, 2020
Amicus Therapeutics receives Priority Medicines (PRIME) Designation from the European Medicines Agency for our investigational medicine for the treatment of CLN6 Batten Disease.
— Amicus Therapeutics (@amicusrx1) September 24, 2020
This Wednesday at the virtual World Orphan Drug Congress USA 2020 our Chairman & CEO John F. Crowley will participate in a keynote panel on navigating a new era for rare disease patients. #wodcusa #raredisease
Full agenda: https://t.co/Wd6n0G1Eju pic.twitter.com/CruGawBCE4
— Amicus Therapeutics (@amicusrx1) August 25, 2020
We are honored that an Amicus product has been nominated for a @GalienFdn 2020 Prix Galien USA award in the “Best Biotechnology Product” category. Congratulations to all nominees. https://t.co/37Ei71Kx3W
— Amicus Therapeutics (@amicusrx1) July 22, 2020
Bradley Campbell, our President and COO, was interviewed by Site Selection Magazine about the scientific revolution that has made Philadelphia a center of excellence for medical innovation. https://t.co/M1drlumyHW pic.twitter.com/OeH39WOB4a
— Amicus Therapeutics (@amicusrx1) July 21, 2020
In an article in Pharmaceutical Executive, John F. Crowley, our Chairman & CEO, and Patrik Florencio, our Chief Compliance & Risk Officer, shared the actions Amicus has taken to build a culture of business ethics. #AmicusCares https://t.co/sLjfYFipXH pic.twitter.com/D0nPADueL6
— Amicus Therapeutics (@amicusrx1) July 13, 2020
We're honored that our Chairman and CEO @johnfcrowley was included in The Healthcare Technology Report's list of the “Top 25 Biotech CEOs of 2020.” Learn more about the award and the other individuals included in the list: https://t.co/9vPv91jmnZ pic.twitter.com/9dxYYrtJEM
— Amicus Therapeutics (@amicusrx1) March 27, 2020
Our Chief Patient Advocate, Jayne Gershkowitz, is featured by @PharmaVOICE, highlighting how her leadership helps strategically insert the patient perspective across the Amicus enterprise. https://t.co/rKovLfpIyk
— Amicus Therapeutics (@amicusrx1) March 10, 2020
For every rare disease, there is a person behind the condition. See their stories: https://t.co/ALylwwGzBu #RareDiseaseWeek
— Amicus Therapeutics (@amicusrx1) February 27, 2020
Rare diseases are anything but rare. With thousands of diseases in existence affecting hundreds of millions of people globally, the fight to treat them should not feel isolated. Learn more and get involved: https://t.co/NiOCyj8Aak #RareDiseaseWeek
— Amicus Therapeutics (@amicusrx1) February 25, 2020
"At the first meeting, there were about 75 people. This year over 2,000 people are attending." @JohnFCrowley, Chairman and CEO of Amicus Therapeutics, talks about the growth of @WORLDSymposia over the past 16 years. #WORLDSymposia https://t.co/LVqEXv7ZtE
— Amicus Therapeutics (@amicusrx1) February 14, 2020
Please join us in congratulating Amicus Chairman and CEO @johnfcrowley for being selected to receive @WORLDSymposia’s 2020 Roscoe O. Brady Award for Innovation and Accomplishment. #WORLDSymposia https://t.co/AiOWj2NgDV pic.twitter.com/Mjpe5wNJ6u
— Amicus Therapeutics (@amicusrx1) February 11, 2020
Many business practices of the biopharmaceutical industry are simply unacceptable when the public health is at stake. Many practices do not put patients first. This must change – and we must be the agents of that change. https://t.co/7H4yyoqXDu
— Amicus Therapeutics (@amicusrx1) January 31, 2020
Amicus announces corporate updates and highlights for #AmicusAnalystDay
— Amicus Therapeutics (@amicusrx1) October 10, 2019
#NewbornScreening has the potential to save lives. Families and advocates are encouraging reform to simplify the NBS system & ensure all infants are screened for a broad range of diseases. Read how the PA community is taking action #2019NBS
— Amicus Therapeutics (@amicusrx1) September 11, 2019
#DYK September is designated as #NewbornScreening Awareness Month? If you’re interested in educational resources on #NBS, check out the @BabysFirstTest’s resource center for materials, fact sheets and more. Help increase awareness and learn more about newborn screening! #2019NBS
— Amicus Therapeutics (@amicusrx1) September 9, 2019
The @EveryLifeOrg 11th Annual Scientific Workshop is today and Amicus is in attendance along with key thought-leaders from industry, the FDA and PAOs, discussing best practices and the path towards alternative trial designs for the rare disease population. https://t.co/BYn61eYCsw pic.twitter.com/v1HD3mo6VZ
— Amicus Therapeutics (@amicusrx1) September 5, 2019
The key to starting off the school year on the right foot when living with a rare disease, is being prepared and open lines of communication with teachers, staff and peers. Check out this @GlobalGenes article for tips on getting ready for the year ahead. https://t.co/UAlMFo9NYO
— Amicus Therapeutics (@amicusrx1) September 3, 2019
This morning, we will present our #2Q19 #FinancialResults and corporate updates. Conference call and webcast at 8:30 a.m. ET. $FOLD #RareCompany #Q2Results
— Amicus Therapeutics (@amicusrx1) August 8, 2019
#ICYMI a full webcast recording of today’s update on interim Phase 1/2 clinical data from our #CLN6 #Batten disease can be found on the Investors Section of the Amicus corporate website. $FOLD
— Amicus Therapeutics (@amicusrx1) August 1, 2019
What an awesome experience to have @2DDPodcast at our all company meeting for a live podcast featuring a panel of three amazing young women living with #RareDisease. Their inspiring messages help keep the Amicus mission moving forward.https://t.co/g0dKo0wjqm
— Amicus Therapeutics (@amicusrx1) July 22, 2019
Amicus is honored that our product is amongst The @GalienFdn’s – 2019 Prix Galien USA Nominees in the category “Best Biotechnology Product.” Check out their tweet below for the full list of nominees! https://t.co/wdzsQLwaIZ
— Amicus Therapeutics (@amicusrx1) July 16, 2019
We are pleased to announce our #GeneTherapy manufacturing collaboration with Brammer Bio, a part of Thermo Fisher Scientific, a partnership that supports our AAV manufacturing strategy for our #BattenDisease and broader portfolio of AAV #GeneTherapy programs. $FOLD
— Amicus Therapeutics (@amicusrx1) July 1, 2019
#DYK we launched our “Life Page” on LinkedIn? Head on over to our page to get the inside scoop on happenings and people at Amicus!
— Amicus Therapeutics (@amicusrx1) June 21, 2019
The bond between Katelynn and her family will never be tarnished by #CDKL5 deficiency disorder. They’ve been with her every step of the way. “You’re okay. We are all right here with you. You are not alone.” #CDKL5AwarenessDay #RareDisease #CommunityOfUs
— Amicus Therapeutics (@amicusrx1) June 17, 2019
Amicus congratulates @Alnylam for expanding into Philadelphia. We look forward to welcoming you into this burgeoning #biotech hub. https://t.co/dk0V5kKH77
— Amicus Therapeutics (@amicusrx1) June 14, 2019
Philadelphia continues to be a buzz after #BIO2019 finished last week with our Mike Diem part of a panel at this morning’s @ChamberPHL Executive Forum. https://t.co/VrWK143iil
— Amicus Therapeutics (@amicusrx1) June 11, 2019
Our very own, Nita Patel was published in the @ClinicalLeader1 on the importance of streamlining #RareDisease clinical trials and incorporating Real World Evidence (RWE) into trial design and execution. #PatientAdvocacy https://t.co/Vi5m4AZm57
— Amicus Therapeutics (@amicusrx1) May 31, 2019
Team Amicus is donating thousands of masks, gloves, gowns, gear, and materials from our labs to organizations in PA and NJ to support caregivers fighting COVID-19 on the front lines. Thank you to those across the globe who are giving, fighting, and persevering. #AmicusCares pic.twitter.com/0GtTVs1jUH
— Amicus Therapeutics (@amicusrx1) April 6, 2020
We’re pleased to have joined @BDSRA for this year’s “Climbing to a Cure” conference in Denver, CO both as participants and supporters. https://t.co/YcRO3ogv8R pic.twitter.com/4qSI2dmidl
— Amicus Therapeutics (@amicusrx1) July 22, 2019
Our Amicus Wellness team organized a fun afternoon full of yoga and make your own Frutta Bowls – Work-life balance keeps us healthy! #RareCompany pic.twitter.com/cisSrs9zfS
— Amicus Therapeutics (@amicusrx1) August 5, 2019
Team Amicus recently participated at the Carnivarty volunteer event with the @holewallcamp at CHOP. Check out these awesome photos of our volunteers! pic.twitter.com/NNl3B0eUsc
— Amicus Therapeutics (@amicusrx1) July 31, 2019
Members of Team Amicus spent Tuesday volunteering at the SCHI School (https://t.co/YDK2eXynsh) working hands-on with the school’s physical therapy staff and students for the day! #HealingBeyondDisease pic.twitter.com/dodPWPkBz4
— Amicus Therapeutics (@amicusrx1) July 19, 2019
We’re halfway through 2019 and Team Amicus has hit the ground running, participating in countless volunteering and fundraising events with our Healing Beyond Disease initiative. Check out this cool snapshot of events so far! #RareCompany pic.twitter.com/lmuJwcwVDD
— Amicus Therapeutics (@amicusrx1) June 27, 2019
Amicus was proud to hit the streets with our own team of cyclists to support a great cause and be a good corporate citizen. in Philadelphia. #raredisease #rarecompany https://t.co/73kJQM63a1
— Amicus Therapeutics (@amicusrx1) June 9, 2019
Team Amicus took part in HomeFront's Rock & Roll for Hope 2019 Race in Princeton, NJ today. Proceeds support the 8-week, award winning Camp Mercer summer camp for over 100 local children who are homeless or at-risk of becoming homeless. https://t.co/8m0LOh6QNg pic.twitter.com/ZLyBd4ajEE
— Amicus Therapeutics (@amicusrx1) June 9, 2019
Today, on #InternationalBattenDay, Amicus joins Batten organizations across the globe as we come together to amplify the voices of the #BattenDisease community. #CommunityOfUs — @BDSRA @BeyondBatten pic.twitter.com/C5bZzfwViG
— Amicus Therapeutics (@amicusrx1) June 9, 2019
Congratulations @GovMurphy on receiving this important recognition. #BIO2019 https://t.co/P3C3sEvAcY
— Amicus Therapeutics (@amicusrx1) June 5, 2019
Amicus’ Chief Portfolio Officer & Head of Gene Therapy, Jeff Castelli, will participate in the Biotech Innovation & Startup Showcase tonight featuring @PennPCI and @PennMedicine. pic.twitter.com/XLnpc7OZhT
— Amicus Therapeutics (@amicusrx1) June 4, 2019
Team Amicus is front row at the official open of @BIOConvention featuring BIO CEO @JimGreenwood and keynote speaker @DrSidMukherjee! #BIO2019 https://t.co/37wyNDNb3q
— Amicus Therapeutics (@amicusrx1) June 4, 2019
We are proud to announce our 2019 Community Star Honoree for Good Grief's Magical Masquerade! @amicusrx1 https://t.co/ehjTU7wEE7
— Good Grief (@GoodGriefNJ) August 27, 2019
We are honored to have Jayne Gershkowitz @jgersh1115 Chief Patient Advocate @amicusrx1 speaking at #TRNDS2019.
Learn about her work empowering #RareDisease patients to be a partner in their healthcare and in the drug development process. https://t.co/S2zLa8WG5I
— TRNDS (@TRNDS_UR) August 2, 2019
https://twitter.com/UpliftingAth/status/1151150092424032260
Did everyone see our big @HuffPost article!?! Please retweet! We are raising $1m to advance a gene therapy that will cure our son of a rare neurological disease. Thank you @HuffPost for covering our story so beautifully.https://t.co/RAQTPrIU05
— Fighting for Maxwell (@Maxs_Milestones) June 17, 2019
We're proud to announce the winners of our inaugural BlueJeans Best-of-Breed Customer Awards! Congratulations to all of our winners! https://t.co/XLSEFTBj1Q @EMDGroup @uofl @GlobalFund @amicusrx1 #videoconferencing #meetings pic.twitter.com/KJaUyWxIVW
— BlueJeans by Verizon (@BlueJeansNet) February 27, 2020
A standing ovation for the inspiration speech from John Crowley, Chairman and CEO, Co-Founder, Amicus Therapeutics, at the 2019 #ISPE Annual Meeting & Expo, where he was a keynote speaker speaking about when drug research is personal. #ISPEAM19 pic.twitter.com/OKkXkKJRQX
— ISPE (@ISPEorg) October 28, 2019
"The greatest skill I believe that a leader can possess and develop is empathy, to feel the hope of another."
We were happy to welcome biotech executive and patient advocate, John F. Crowley, CEO of Amicus Therapeutics, for today's 2019 Mason Public Leadership Lecture! pic.twitter.com/bnXr1uMoQQ
— Terry College | UGA (@TerryCollege) September 20, 2019
We had an amazing time sitting down and interviewing John Crowley, Chaiman and CEO of @amicusrx1 Amicus is a biotechnology firm that chose Philadelphia as the site for its research operations and gene therapy center! @CICPhilly @UCScienceCenter @PhiladelphiaGov @uCitySquare pic.twitter.com/SCIoQczrWF
— Invest: Philly (@Invest_Philly) June 19, 2019
“Get out of your own head and question what is driving your fear,” said Dunni Odumosu, Director of Global Regulatory Affairs at @amicusrx1. #STEM #FoxSTEM4Women pic.twitter.com/nYtfKoDpEA
— Fox Rothschild LLP (@FoxRothschild) June 19, 2019
Visiting an amazing place in Central New Jersey for what promises to be an amazing event put on by our friends @amicusrx1 – thanks for inviting us! pic.twitter.com/UdawmP1TG4
— Ed Tate (@edwardtate) June 18, 2019
John Crowley, CEO of @amicusrx1, left a job in finance to immerse himself in pharma working to develop treatments for 2 of his children diagnosed w. Pompe disease. Crowley + his family inspired the movie Extraordinary Measures. A gene therapy leader, John defines #NJinnovation. pic.twitter.com/JWzDrc65Cv
— Choose New Jersey (@ChooseNJ) June 11, 2019
.@amicusrx1’s Michael Diem, @PennMedicine’s Jonathan Epstein, and @TmunityTx’s Lori Gavrin share insights into the disruptive changes happening in the pharmaceutical industry in #GreaterPHL. #GoodBizPHL pic.twitter.com/TZ7nSvpnnU
— Chamber for Gtr PHL (@ChamberPHL) June 11, 2019
Mike Diem of @amicusrx1 learned from speaking with patients & caregivers that incremental improvements (such as the ability to brush their teeth) can make a difference in patient lives. #RDDS2019 #pennmedmdbr2019
— Stephanie Fischer (@RarePOV) June 7, 2019
I spent yesterday afternoon touring the labs at @amicusrx1 in Philly. This lab is filled with these beautiful solemn reminders of why the work is being done. It is so easy to lose sight of the patient from the lab – huge props to Amicus for being a leader in making this a focus. pic.twitter.com/gjuVJkARUi
— Benjamin Forred (@SanfordBenF) June 7, 2019
Immensely appreciative for people like Alex who live with rare disease and make the valiant commitment to be part of clinical research. Humbled by today’s plenary #BIO2019 #ItStartsWithOne #rarediseases #PatientAdvocacy @amicusrx1 pic.twitter.com/ieP4iq1sOw
— jayne gershkowitz (@jgersh1115) June 5, 2019
Jane Gershkowitz, Chief Patient Advocate @amicusrx1, stopped by to ‘Meet Max’ in the NJ Pavilion (Booth #1501)! #PatientsCantWait #BIO2019 pic.twitter.com/102fBcPDlc
— BioNJ (@BioNJ_Org) June 4, 2019
Gene therapy innovators like Dr. Jim Wilson are drawing companies like @amicusrx1 to #Philly, leading to research collabs & clinical trials paving the way to first-ever treatments & cures for many rare diseases. @comcast @CEOCouncilPHL #BIO2019 pic.twitter.com/neu5l229jk
— Penn Medicine News (@PennMedNews) June 3, 2019
The lineup for our 6th #NGLY1 conference. A fabulous roster of world-class researchers & scientific advisors. Thank you, @amicusrx1, @AudentesTx, BridgeBio & Ultragenyx, for your sponsorship that helped bring this talented group together. #collaboration #RareDisease pic.twitter.com/FtD4DU83Hh
— Grace Science (@gracescience) August 2, 2019
Our 6th #NGLY1 conference brought together amazing talent. At the center were patients like Devon & their families. They provide the fuel & inspiration to #cure NGLY1 Deficiency. Our thanks to @amicusrx1, @AudentesTx, BridgeBio & Ultragenyx for helping us bring everyone together. pic.twitter.com/SBuBTIab5T
— Grace Science (@gracescience) August 8, 2019
Want to learn more about the latest #biotech discoveries in northern Delaware, southeastern Pennsylvania, and southern New Jersey? Check out Select's new publication, Business is Greater Here. #GreaterHere https://t.co/CvBOQeIOY6 pic.twitter.com/muoyP1Wt6P
— Select Greater PHL (@SelectPHL) July 5, 2019
We had the opportunity to locate anywhere in the country and it was this regions entrepreneurship, top medical schools, innovation, and talent all in a close proximity that made it easy to stay here. – Bradley Campbell @amicusrx1. #GreaterHere #BIO2019 #TalentResearchResultsPHL
— Select Greater PHL (@SelectPHL) June 3, 2019